Nuwellis Inc vs TransMedics Group Inc — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TransMedics Group Inc is far larger — about 2330.3× Nuwellis Inc's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | TMDX | |
|---|---|---|
Market Cap | $1.09M | $2.54B |
Sector | Technology | Technology |
52-Week High | $527.46 | $150.42 |
52-Week Low | $2.80 | $61.99 |
Enterprise Value | -$722.58K | $2.94B |
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →